Nuvation Bio Inc. Income Statement

Income Statement Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Revenue & cost
Revenue 1.44M727000.005.71M3.08M4.83M13.12M
Gross Profit 88000.00-788000.001.50M990000.002.26M9.77M
Operating items
Research & Development 7.29M7.34M8.63M9.34M15.88M14.03M17.12M22.00M20.73M28.92M21.29M16.87M18.79M18.59M18.56M15.35M12.84M29.25M27.73M29.30M24.60M27.36M28.85M
Wages, Salaries and Other 60000.0056000.0052000.00103000.00108000.00176000.00170000.00190000.00169000.00215000.00263000.00225000.00230000.00231000.00228000.00260000.00265000.00247000.00237000.00227000.00203000.00182000.00171000.00
Selling, General & Administrative 1.93M1.67M2.92M4.43M4.61M6.40M5.67M7.61M7.46M8.95M8.04M7.46M7.73M7.54M7.78M5.48M7.36M16.16M19.58M26.14M35.39M38.48M37.36M
Other Operating Expenses 425.07M
Operating Expenses 9.22M9.02M11.55M13.77M20.48M20.43M22.79M29.61M28.19M37.87M29.34M24.34M26.52M26.13M26.34M20.83M20.20M470.47M47.31M55.44M59.99M65.85M66.20M
Operating Income -9.22M-9.02M-11.55M-13.77M-20.48M-20.43M-22.79M-29.61M-28.19M-37.87M-29.34M-24.34M-26.52M-26.13M-26.34M-20.83M-20.20M-470.38M-48.10M-53.94M-59.00M-63.59M-56.43M
EBIT -9.22M-9.02M-11.55M-13.77M-20.48M-20.43M-22.79M-29.61M-28.19M-37.87M-29.34M-24.34M-26.52M-26.13M-26.34M-20.83M-20.20M-470.38M-48.10M-53.94M-59.00M-63.59M-56.43M
Non-operating items
Non Operating Investment Income -96000.0012000.0044000.001000.00-7000.00-11000.005000.003000.00-1000.00
Interest & Investment Income 519000.00522000.00445000.00459000.00438000.00776000.00847000.00902000.00958000.00841000.002.13M3.52M4.98M6.09M6.52M7.02M7.13M7.14M6.73M6.06M5.32M4.78M6.03M
Non Operating Income 474000.00418000.00512000.00488000.0082000.001.10M812000.004.47M6.90M3.01M2.13M3.49M4.79M5.49M6.69M7.04M5.41M7.89M6.89M4.50M5.77M4.58M642000.00
Net income details
EBT -8.75M-8.60M-11.03M-13.28M-20.40M-19.33M-21.98M-25.13M-21.29M-34.86M-27.20M-20.84M-21.73M-20.64M-19.65M-13.79M-14.79M-462.49M-41.21M-49.45M-53.24M-59.01M-55.79M
Profit After Tax -8.75M-8.60M-11.03M-13.28M-20.40M-19.33M-21.98M-25.13M-21.29M-34.86M-27.20M-20.84M-21.73M-20.64M-19.65M-13.79M-14.79M-462.49M-41.21M-49.45M-53.24M-59.01M-55.79M
Income from Continuing Operations -8.75M-8.60M-11.03M-13.28M-20.40M-19.33M-21.98M-25.13M-21.29M-34.86M-27.20M-20.84M-21.73M-20.64M-19.65M-13.79M-14.79M-462.49M-41.21M-49.45M-53.24M-59.01M-55.79M
Consolidated Net Income -8.75M-8.60M-11.03M-13.28M-20.40M-19.33M-21.98M-25.13M-21.29M-34.86M-27.20M-20.84M-21.73M-20.64M-19.65M-13.79M-14.79M-462.49M-41.21M-49.45M-53.24M-59.01M-55.79M
Income towards Parent Company -8.75M-8.60M-11.03M-13.28M-20.40M-19.33M-21.98M-25.13M-21.29M-34.86M-27.20M-20.84M-21.73M-20.64M-19.65M-13.79M-14.79M-462.49M-41.21M-49.45M-53.24M-59.01M-55.79M
Net Income towards Common Stockholders -8.75M-8.60M-11.03M-13.28M-20.40M-19.33M-21.98M-25.13M-21.29M-34.86M-27.20M-20.84M-21.73M-20.64M-19.65M-13.79M-14.79M-462.49M-41.21M-49.45M-53.24M-59.01M-55.79M
Additional items
EPS (Basic) -0.10-0.10-0.12-0.11-0.12-0.09-0.11-0.12-0.10-0.16-0.12-0.09-0.10-0.09-0.09-0.07-0.07-1.89-0.15-0.15-0.16-0.17-0.16
EPS (Weighted Average and Diluted) -94.76-106.13-0.44-0.10-0.16-0.12-0.09-0.10-0.09-0.09-0.07-0.07-1.89-0.15-183.97-0.16-0.17-0.16
Shares Outstanding (Weighted Average) 16.07M18.46M18.46M217.65M217.65M217.76M217.79M219.06M218.14M218.24M218.39M218.80M218.80M218.94M218.94M219.05M247.17M249.25M336.57M338.68M340.26M342.27M
Shares Outstanding (Diluted Average) 204017.00207101.00197887.00213411.00216603.00218300.00216721.00218741.00218848.00218935.00218880.00219048.00244738.00273565.00268772.00338612.00340746.00342393.00
EBITDA -9.22M-9.02M-11.55M-40.52M-20.48M-20.98M-22.35M-26.71M-28.19M-26.32M-28.34M-18.25M-26.52M-19.14M-18.55M-10.31M-16.14M-462.59M-38.56M-50.25M-53.26M-59.88M-55.60M
Shares Outstanding 114.57M114.57M114.57M91.40M216.65M216.76M216.78M216.95M217.13M217.24M217.39M217.63M217.80M217.90M217.94M218.05M218.08M247.62M335.25M336.84M338.84M341.23M341.76M